116 related articles for article (PubMed ID: 32914663)
1. PIM-1 may function as an oncogene in cervical cancer via activating the EGFR signaling.
Yang H; He K; Dong W; Fang J; Zhong S; Tang L; Long L
Int J Biol Markers; 2020 Sep; 35(3):67-73. PubMed ID: 32914663
[TBL] [Abstract][Full Text] [Related]
2. PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells.
Siu A; Virtanen C; Jongstra J
Oncotarget; 2011 Dec; 2(12):1134-44. PubMed ID: 22193779
[TBL] [Abstract][Full Text] [Related]
3. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract][Full Text] [Related]
4. Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer.
Pang W; Tian X; Bai F; Han R; Wang J; Shen H; Zhang X; Liu Y; Yan X; Jiang F; Xing L
Mol Cancer; 2014 Oct; 13():240. PubMed ID: 25342548
[TBL] [Abstract][Full Text] [Related]
5. Computational prediction and experimental validation of a novel synthesized pan-PIM inhibitor PI003 and its apoptosis-inducing mechanisms in cervical cancer.
Liu Z; He W; Gao J; Luo J; Huang X; Gao C
Oncotarget; 2015 Apr; 6(10):8019-35. PubMed ID: 25749522
[TBL] [Abstract][Full Text] [Related]
6. miR-133a inhibits cervical cancer growth by targeting EGFR.
Song X; Shi B; Huang K; Zhang W
Oncol Rep; 2015 Sep; 34(3):1573-80. PubMed ID: 26134491
[TBL] [Abstract][Full Text] [Related]
7. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
8. Role of oncogene PIM-1 in the development and progression of papillary thyroid carcinoma: Involvement of oxidative stress.
Wen QL; Yi HQ; Yang K; Yin CT; Yin WJ; Xiang FY; Bao M; Shuai J; Song YW; Ge MH; Zhu X
Mol Cell Endocrinol; 2021 Mar; 523():111144. PubMed ID: 33383107
[TBL] [Abstract][Full Text] [Related]
9. Pim-1 kinase expression predicts radiation response in squamocellular carcinoma of head and neck and is under the control of epidermal growth factor receptor.
Peltola K; Hollmen M; Maula SM; Rainio E; Ristamäki R; Luukkaa M; Sandholm J; Sundvall M; Elenius K; Koskinen PJ; Grenman R; Jalkanen S
Neoplasia; 2009 Jul; 11(7):629-36. PubMed ID: 19568408
[TBL] [Abstract][Full Text] [Related]
10. Detection of epidermal growth factor receptor mRNA in peripheral blood of cervical cancer patients.
Mitsuhashi A; Tanaka N; Suzuka K; Matsui H; Seki K; Sekiya S
Gynecol Oncol; 2003 Jun; 89(3):480-5. PubMed ID: 12798715
[TBL] [Abstract][Full Text] [Related]
11. SGI-1776, an imidazo pyridazine compound, inhibits the proliferation of ovarian cancer cells by inactivating Pim-1.
Xie J; Bai J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 39(7):649-57. PubMed ID: 25080901
[TBL] [Abstract][Full Text] [Related]
12. Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases.
Warnecke-Eberz U; Bollschweiler E; Drebber U; Pohl A; Baldus SE; Hoelscher AH; Metzger R
Oncol Rep; 2008 Sep; 20(3):619-24. PubMed ID: 18695914
[TBL] [Abstract][Full Text] [Related]
13. Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.
Li F; Cui J
Med Oncol; 2015 Jul; 32(7):199. PubMed ID: 26067630
[TBL] [Abstract][Full Text] [Related]
14. Pim-1 kinase inhibits the activation of reporter gene expression in Elk-1 and c-Fos reporting systems but not the endogenous gene expression: an artifact of the reporter gene assay by transient co-transfection.
Yan B; Wang H; Kon T; Li CY
Braz J Med Biol Res; 2006 Feb; 39(2):169-76. PubMed ID: 16470303
[TBL] [Abstract][Full Text] [Related]
15. PIM kinases 1, 2 and 3 in intracellular LIF signaling, proliferation and apoptosis in trophoblastic cells.
Mary Photini S; Chaiwangyen W; Weber M; Al-Kawlani B; Favaro RR; Jeschke U; Schleussner E; Morales-Prieto DM; Markert UR
Exp Cell Res; 2017 Oct; 359(1):275-283. PubMed ID: 28729093
[TBL] [Abstract][Full Text] [Related]
16. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway.
Zhao R; Song J; Jin Y; Liu Y
J Mol Histol; 2021 Oct; 52(5):991-1006. PubMed ID: 34387789
[TBL] [Abstract][Full Text] [Related]
18. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
Wingett D; Long A; Kelleher D; Magnuson NS
J Immunol; 1996 Jan; 156(2):549-57. PubMed ID: 8543805
[TBL] [Abstract][Full Text] [Related]
19. Constitutively activated FLT3 phosphorylates BAD partially through pim-1.
Kim KT; Levis M; Small D
Br J Haematol; 2006 Sep; 134(5):500-9. PubMed ID: 16869825
[TBL] [Abstract][Full Text] [Related]
20. The proto-oncogene Pim-1 is a target of miR-33a.
Thomas M; Lange-Grünweller K; Weirauch U; Gutsch D; Aigner A; Grünweller A; Hartmann RK
Oncogene; 2012 Feb; 31(7):918-28. PubMed ID: 21743487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
